Renal CLCN5 gene therapy for Dent disease type 1: local rapamycin immune modulation and age-dependent outcomes with lentiviral and AAV9 vectors
Pin Lyu, Aykut Bostanci, Cuili Jiang, Kyung What Yoo, Rhyston Broadhurst, Anthony Atala, Baisong Lu Gene Therapy
· Springer Nature
· 2026-11-02
· DOI: 10.1038/s41434-026-00655-9
Аннотация
Gene Therapy, Published online: 02 November 2026; doi:10.1038/s41434-026-00655-9 Renal CLCN5 gene therapy for Dent disease type 1: local rapamycin immune modulation and age-dependent outcomes with lentiviral and AAV9 vectors
Pin Lyu, Aykut Bostanci, Cuili Jiang, Kyung What Yoo, Rhyston Broadhurst, Anthony Atala et al. Renal CLCN5 gene therapy for Dent disease type 1: local rapamycin immune modulation and age-dependent outcomes with lentiviral and AAV9 vectors. // Gene Therapy. – 2026. – DOI: 10.1038/s41434-026-00655-9. – URL: https://www.nature.com/articles/s41434-026-00655-9
Pin Lyu, Aykut Bostanci, Cuili Jiang, Kyung What Yoo, Rhyston Broadhurst, Anthony Atala, & Baisong Lu (2026). Renal CLCN5 gene therapy for Dent disease type 1: local rapamycin immune modulation and age-dependent outcomes with lentiviral and AAV9 vectors. Gene Therapy. https://doi.org/10.1038/s41434-026-00655-9
Pin Lyu, et al. “Renal CLCN5 gene therapy for Dent disease type 1: local rapamycin immune modulation and age-dependent outcomes with lentiviral and AAV9 vectors.” Gene Therapy, 2026. doi:10.1038/s41434-026-00655-9.
@article{Lyu2026,
title = {Renal CLCN5 gene therapy for Dent disease type 1: local rapamycin immune modulation and age-dependent outcomes with lentiviral and AAV9 vectors},
author = {Lyu, Pin and Bostanci, Aykut and Jiang, Cuili and Yoo, Kyung What and Broadhurst, Rhyston and Atala, Anthony and Lu, Baisong},
journal = {Gene Therapy},
year = {2026},
doi = {10.1038/s41434-026-00655-9},
url = {https://www.nature.com/articles/s41434-026-00655-9}
}
Gene Therapy, Published online: 13 November 2026; doi:10.1038/s41434-026-00658-6 Clinical landscape of gene therapy for rare diseases: a registry-based analysis of clinical trials and FDA-approved products
Human Genome Variation, Published online: 12 November 2026; doi:10.1038/s41439-026-00361-3 Arthrogryposis involves multiple joint contractures present at birth, affecting both upper and lower extremities. This study investigates the...
Gene Therapy, Published online: 10 November 2026; doi:10.1038/s41434-026-00657-7 Perspectives on cell and gene therapy: insights from the 5th China Annual Congress on CGT
Gene Therapy, Published online: 04 November 2026; doi:10.1038/s41434-026-00649-7 High-resolution separation and quantification of dual-AAV drug products by density gradient equilibrium analytical ultracentrifugation
Gene Therapy, Published online: 03 November 2026; doi:10.1038/s41434-026-00656-8 Genotoxic safety and long-term engraftment dynamics of efficient translational CRISPR/Cas9 therapeutics for β-haemoglobinopathies from bench to clinical trials